| back to TNF products | | | This is a review about TNF-alpha antibodies, based on 18 published articles using TNF-alpha antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited TNF-alpha antibody. Information in this review (with links to publications) can be searched freely. |
| list by method:
blocking or activating expriments,
ELISA,
immunocytochemistry,
immunohistochemistry,
immunoprecipitation,
western blot |
R&D SYSTEMS
Other Brands or Spellings: R & D SYSTEMS, R&D, RNDSYSTEMS, R & D SYSTEM |
|
R & D Systems anti-TNF-alpha antibody was used in blocking experiments by Mark Bond et al. to study the induction a Fas-associated death domain-dependent type II apoptotic pathway by tissue inhibitor of metalloproteinase-3 in 2002, by Min Zhou et al. to study the regulation of monocyte matrix metalloproteinase-1 and -9 by interferon-gamma in 2003, and by Bysani Chandrasekar et al. (AF-201-NA) to study the proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death in 2004.
R&D Systems TNF alpha ELISA kit was used in 2003 by Terese Persson-Dajotoy et al. to study TNF alpha expression in human eosinophils, and by Shigeru Okumura et al. to study TLR4- and Fc{epsilon}RI mediated gene expression in human mast cells, and in 2004 by Thorsten Hagemann et al. to study up-regulation of matrix metalloproteases by TNF alpha, and by Iveta Iontcheva et al. to study moesin role in lipopolysaccharide-stimulated signal transduction. In 2003, R & D Systems monoclonal anti-TNF-alpha antibody was used in immunocytochemistry to study expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils, and in immunohistochemistry by Terese Persson-Dajotoy et al. study TNF alpha expression in human eosinophils.
|
BD PHARMINGEN
Other Brands or Spellings: BD BIOSCIENCES, BD, BD BIOSCIENCES CLONTECH, BD BIOSCIENCES PHARMINGEN, BD TRANSDUCTION LABORATORIES, BD TRANSDUCTION LABORATORY, TRANSDUCTION LABORATORIES, PHARMINGEN, PHARMINOGEN, BECTON DICKINSON, TRANSDUCTION LABORATORY, BECTON DICKINSON TRANSDUCTION LABORATORIES, BD TRANSDUCTION |
| L Fong et al. used BD PharMingen TNF-alpha antibody in ELISA to study xenoantigen vaccination for prostate cancer in 2001. E Verajakorva et al. used Pharmingen mouse anti-human TNF-a antibody (clone Mab11) in western blot and immunohistochemistry to study CD99 and CD106 (VCAM-1) expression in human testis in 2002. Shigeru Okumura et al. used the same clone in immunocytochemistry to study TLR4- and Fc{epsilon}RI mediated gene expression in human mast cells in 2003.
|
BIOSOURCE
Other Brands or Spellings: INVITROGEN, BIOSOURCE INTERNATIONAL, ZYMED, ZYMED LABORATORIES, CALTAG, MOLECULAR PROBES, MEDGENIX DIAGNOSTICS, MEDGENIX, DYNAL ASA |
|
BIOSOURCE TNFalpha ELISA assay was used in 2002 by Petra Muenzner et al. to study the N. gonorrhoeae-induced CEACAM up-regulation in epithelial cells directed by nuclear factor-kappa B, in 2003 by Stefanie Galban et al. to study von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation and by Jose Hernandez-Rodriguez et al. to study interleukin-6 level in giant-cell arteritis patients, and by Chieh-An Liu et al. to study TNF alpha-induced apoptosis of neonatal blood granulocytes in 2005.
|
| ROCHE DIAGNOSTICS GMBH |
| In 2004, Juerg Gertsch et al. used Roche Diagnostics GmbH hTNF-alpha ELISA kit to study TNF-alpha gene expression. |
UPSTATE BIOTECHNOLOGY
Other Brands or Spellings: CHEMICON, UPSTATE BIOTECHNOLOGIES, UPSTATE, CHEMICON INTERNATIONAL, UPSTATE CELL SIGNALING, UPSTATE CELL SIGNALING SOLUTIONS, UPSTATE BIOTECH, UPSTATE BIOTECHNOLOGY INC, UPSTATE LABORATORIES |
| In 2005, Eun Ok Lee et al. used Upstate Biotechnology anti-human TNF-alpha antibody in blocking expriments to study matrix metalloproteinase-2 production in human monocytic THP-1 cells. |
IMMUNOTECH
Other Brands or Spellings: BECKMAN COULTER, IMMUNOTECH-COULTER, IMMUNOTECH INTERNATIONAL, COULTER-IMMUNOTECH, COULTER IMMUNOTECH |
| In 2003, Min Zhou et al. used Immunotech TNF alpha enzyme-linked immunosorbent assay to study regulation of monocyte matrix metalloproteinase-1 and -9 by interferon-gamma.
|
| BENDER SYSTEMS |
| In 2006, Juergen Luhm et al. used Bender Systems TNF alpha ELISA ket to study inflammatory response induced by glucan. |
| IMUNOGENEX CORPORATION |
| In 2002 Gabriel Thabut et al. used Imunogenex Corporation anti-TNF antibody in blocking or activating expriments to study its effect on airway smooth muscle oxidants production. |
| GENZYME |
| In 2003, Jose Hernandez-Rodriguez et al. used Genzyme rabbit polyclonal anti-human TNF-alpha antibody in immunohistochemistry to interleukin-6 level in giant-cell arteritis patients. |
Articles Reviewed | | 1. L Fong et al. Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy. 2001 | | 2. Petra Muenzner et al. Nuclear factor-kappa B directs carcinoembryonic antigen-related cellular adhesion molecule 1 receptor expression in Neisseria gonorrhoeae-infected epithelial cells. 2002 | | 3. Mark Bond et al. Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway. 2002 | | 4. Gabriel Thabut et al. Tumor necrosis factor-alpha increases airway smooth muscle oxidants production through a NADPH oxidase-like system to enhance myosin light chain phosphorylation and contractility. 2002 | | 5. E Veräjäkorva et al. CD 99 and CD 106 (VCAM-1) in human testis. 2002 | | 6. Stefanie Galbán et al. von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays. 2003 | | 7. T Persson et al. Expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils. 2003 | | 8. Terese Persson-Dajotoy et al. Expression and production of the CXC chemokine growth-related oncogene-alpha by human eosinophils. 2003 | | 9. José Hernández-Rodríguez et al. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. 2003 | | 10. Shigeru Okumura et al. Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. 2003 | | 11. Min Zhou et al. Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. 2003 | | 12. Bysani Chandrasekar et al. Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. 2004 | | 13. Iveta Iontcheva et al. Role for moesin in lipopolysaccharide-stimulated signal transduction. 2004 | | 14. Thorsten Hagemann et al. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. 2004 | | 15. Juerg Gertsch et al. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways. 2004 | | 16. Eun Ok Lee et al. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. 2005 | | 17. Chieh-An Liu et al. Higher spontaneous and TNFalpha-induced apoptosis of neonatal blood granulocytes. 2005 | | 18. Juergen Luhm et al. Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio. 2006 |
|